These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8036452)

  • 1. Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates.
    Wu J; Danielsson A
    Scand J Gastroenterol; 1994 May; 29(5):385-91. PubMed ID: 8036452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for hepatic fibrosis.
    Brenner DA; Alcorn JM
    Semin Liver Dis; 1990 Feb; 10(1):75-83. PubMed ID: 2186490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is reliable in therapy of liver fibrosis?].
    Högemann B
    Z Gastroenterol; 1992 May; 30(5):333-6. PubMed ID: 1321534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis.
    Takase S; Takada A; Yasuhara M; Sato H; Matsuda Y
    Gastroenterol Jpn; 1988 Dec; 23(6):639-45. PubMed ID: 2851477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of malotilate on carbon tetrachloride-induced liver damage and collagen accumulation in the rat.
    Ala-Kokko L; Stenbäck F; Ryhänen L
    Biochem J; 1987 Sep; 246(2):503-9. PubMed ID: 2825640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
    Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
    J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet.
    Sakaida I; Matsumura Y; Kubota M; Kayano K; Takenaka K; Okita K
    Hepatology; 1996 Apr; 23(4):755-63. PubMed ID: 8666329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-fibrotic effect of malotilate on liver fibrosis induced by carbon tetrachloride in rats.
    Igarashi S; Hatahara T; Nagai Y; Hori H; Sakakibara K; Katoh M; Sakai A; Sugimoto T
    Jpn J Exp Med; 1986 Oct; 56(5):235-45. PubMed ID: 3027433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and pharmacologic modulation of hepatic fibrosis.
    Leveille CR; Arias IM
    J Vet Intern Med; 1993; 7(2):73-84. PubMed ID: 8501699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental studies of the inhibition of fibrogenesis].
    Böker K; Schwarting G; Kaule G; Günzler V; Ohlendorf S; Schmidt E
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():43-5. PubMed ID: 1333142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of fibrogenesis in liver diseases].
    Szántová M; Kupcová V
    Bratisl Lek Listy; 1999 Jan; 100(1):28-35. PubMed ID: 10492995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver collagen hydroxylation in murine schistosomiasis.
    Dunn MA; Maragoudakis ME; Hait PK
    Biochim Biophys Acta; 1978 Jan; 538(2):328-33. PubMed ID: 202335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals.
    Chen RJ; Wu HH; Wang YJ
    Arch Toxicol; 2015 Oct; 89(10):1727-50. PubMed ID: 25963329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice.
    Bansal R; Prakash J; Post E; Beljaars L; Schuppan D; Poelstra K
    Hepatology; 2011 Aug; 54(2):586-96. PubMed ID: 21538439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
    Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of malotilate treatment on alcoholic liver disease.
    Takase S; Matsuda Y; Yasuhara M; Takada A
    Alcohol; 1989; 6(3):219-22. PubMed ID: 2544209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of liver fibrosis in alcoholics: 1996 update.
    Lieber CS
    Dig Dis; 1997; 15(1-2):42-66. PubMed ID: 9101129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic fibrogenesis].
    Lee KS
    Korean J Gastroenterol; 2006 Nov; 48(5):297-305. PubMed ID: 17132917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease.
    Mann SW; Fuller GC; Rodil JV; Vidins EI
    Gut; 1979 Oct; 20(10):825-32. PubMed ID: 230128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
    Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
    Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.